Precede Biosciences
Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.
About Precede Biosciences
Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology. The company aims to increase drug development success rates and to contribute to a future in which every patient can receive a speedy, minimally invasive diagnosis and therapy tailored to the biology of their condition. It provides a genome-wide platform that simultaneously explores the dynamic, feature-rich space of gene promoters, gene enhancers, and the DNA methylome from a single milliliter (1 mL) of plasma. It is actively partnering with drug developers to accelerate the development of precision medicines by identifying the biology associated with response and resistance to treatment and by identifying targets mechanistically linked to disease biology.
Company Facts
- Headquarters
- Boston
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $140,500,000
- Last Funding Type
- series_b
- Last Funding Date
- 2026-01-12
- Website
- precede.bio
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Social Links
Canonical: https://fsome.com/organization/precede-biosciences-11415 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.